These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15644306)

  • 21. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
    Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
    André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
    Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
    Seggewiss R; Einsele H
    Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Duran-Struuck R; Reddy P
    Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
    Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
    Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
    [No Abstract]   [Full Text] [Related]  

  • 28. The thymus in GVHD pathophysiology.
    Krenger W; Holländer GA
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):119-28. PubMed ID: 18503980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
    Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune reconstitution: from stem cells to lymphocytes.
    Crooks GM; Weinberg K; Mackall C
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):42-6. PubMed ID: 16399583
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Remberger M
    Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
    [No Abstract]   [Full Text] [Related]  

  • 35. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation.
    Cohen JL; Salomon BL
    Cytotherapy; 2005; 7(2):166-70. PubMed ID: 16040396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.
    Teshima T; Matsuoka K; Ichinohe T
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):165-72. PubMed ID: 16652218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
    Banning U; Lange T; Krahl R; Mauz-Körholz C; Krutmann J; Niederwieser D; Körholz D
    Bone Marrow Transplant; 2005 Apr; 35(7):691-7. PubMed ID: 15696178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.